Stem Cell Therapy Market Size to Reach USD 5,040 Million by 2028

Vancouver, British Columbia, Jan. 29, 2021 (GLOBE NEWSWIRE) — Stem Cell Therapy Market Size to Reach USD 5,040 Million by 2028 | Rising Public-Private Investments and Developing Regulatory Framework for Stem Cell Therapeutics will be the Key Factor Driving the Industry Growth, States Emergen Research

The global stem cell therapy market size was valued at USD 342.7 Million in 2019 and is anticipated to reach USD 3,693.6 Million by 2027 at a CAGR of 36.2%, over the forecast period, according to most recent analysis by Emergen Research.

Growing prevalence of chronic diseases will drive the growth of the stem cell therapy market. Increased investment in research activities, development of advanced genetic techniques, and rise in public-private partnership will contribute to the growth of the stem cell therapy market.

Stem cells are used to improve health and manage disease. The growing popularity of regenerative medicine has encouraged the growth of stem cell therapy market. Regenerative medicines are used to replace, repair, and regenerate tissues affected by disease, injury, and aging process. Regenerative medicines are used in research to find a cure for diabetes, Parkinson’s, and Alzheimer’s disease.

Claim Your FREE Sample Copy with Table of content@

However, ethical concerns regarding embryonic stem cells and less developed research infrastructure will hinder the stem cell therapy market’s growth.

Companies Profiled in Stem Cell Therapy Market Research Report:

Virgin Health Bank, Celgene Corporation, ReNeuron Group plc, Biovault Family, Precious Cells International Ltd., Mesoblast Ltd., Opexa Therapeutics, Inc., Caladrius, Neuralstem, Inc., and Pluristem.

Key Highlights of Report

  • Autologous stem cell therapy is growing at a higher rate during the forecast period due to the low risk of complications associated with autologous treatment. Other factors expected to drive the growth of the segment are the improved survival rate of patients, affordability, and no risk of graft-versus-host diseases.
  • Diabetes is a growing cause of concern all across the globe. In 2019, approximately 463 million adults had diabetes, and the number is expected to grow to 700 million by 2045. Stem cell therapy offers greater potential for enhancing glucose control in patients with type 1 diabetes, which will drive the growth of the segment.
  • Clinic segment is growing at a rate of 36.4% during the forecast period as they are equipped with sophisticated equipment and reagents for use in stem cell therapies. Clinics are offering stem cell therapies, but the cost of the treatment is high.
  • The stem cell therapy market is growing in Asia Pacific due to increasing collaboration between research institutes and industries for development of drugs to treat chronic diseases. In 2019, AVITA Medical in Australia collaborated with scientists at the Gates Center for regenerative medicine at the University Of Colorado School Of Medicine to explore development of spray-on treatment of genetically modified cells for patients.

Check Our Prices@
Emergen Research has segmented the global stem cell therapy market in terms of type, application, end-users, and region:

  • Type Outlook (Revenue, USD Million; 2018-2028)
    • Allogeneic Stem Cell Therapy
    • Autologous Stem Cell Therapy
  • Application Outlook (Revenue, USD Million; 2018-2028)
    • Regenerative Medicine
      1. Orthopedics
      2. Neurology
      3. Hematology stem cells
      4. Soft tissue injuries
      5. Cardiovascular and myocardial infarction-based
      6. Oncology
      7. Diabetes
      8. Liver Disorder
      9. Others
    • Drug discovery & development
  • End-users Outlook (Revenue, USD Million; 2018-2028)

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:

  • Regional Outlook (Revenue, USD Million; 2018–2028)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. UK
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. Rest of Middle East & Africa

Take a Look at our Related Reports:

AI-Enabled Medical Imaging Solutions Market By Product (Software, Hardware), By Workflow (Image Acquisition, Image Analysis, Reporting, and Communication), By Therapeutic Application (General Imaging, Specialty Imaging), By Deployment Mode, By Modality, and By Region, Forecasts to 2027

Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027

Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release@

Source link

Add a Comment